Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI‐1) and tolerance induction with rituximab/prednisone
暂无分享,去创建一个
J. Tisdale | M. Lee | M. Hsieh | J. Lozier | K. Nghiem | B. Hodsdon | G. Joe | R. P. Weitzel
[1] J. Oldenburg,et al. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients. , 2013, Blood.
[2] A. Ganser,et al. Acquired haemophilia caused by non-haemophilic factor VIII gene variants , 2010, Annals of Hematology.
[3] L. Almasy,et al. Inhibitors of factor VIII in black patients with hemophilia. , 2009, The New England journal of medicine.
[4] K. Mann,et al. Quantitation of anti-factor VIII antibodies in human plasma. , 2009, Blood.
[5] C. Kessler,et al. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. , 1993, Blood.
[6] M. Kazatchkine,et al. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Stockman. Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease , 2011 .